Meta AnalysisID 5802
4种中成药治疗慢性心力衰竭的疗效与安全性：网状Meta分析
CRD42019129221
What is the difference of therapeutic effect of 4 kinds of personal Chinese patent medicines on patients with chronic heart failure?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 5802
- Evidence Id
- 14360
- Core Evidence Id
- 14360
- Source Meta Analysis Id
- 5785
- Herb2 Meta Analysis Id
- HBMA005785
- Crd Id
- CRD42019129221
- Title
- Efficacy and safety of 4 personal Chinese patent medicines in the treatment of chronic heart failure: a network meta-analysis
- Review Question
- What is the difference of therapeutic effect of 4 kinds of personal Chinese patent medicines on patients with chronic heart failure?
- Study Type Included
- We will include randomised trials to assess the beneficial effects and side effects of the treatments for chronic heart failure.
- Condition Being Studied
- Efficacy and safety of personal Chinese patent medicine in the treatment of chronic heart failure
- Participant
- Inclusion: Patients with chronic heart failure and Cardiac function class II-IV (2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and NYHA Cardiac Function Classification). Exclusion: Failure to meet inclusion criteria.
- Animal
- Human Disease Modelled
- Intervention
- The 4 species of Chinese patent medicines of Xinbao Pill、Shengmai Capsule、Shenfu Qiangxin Pill and Buyi Qiangxin Tablet for chronic heart failure.
- Comparator Control
- Conventional Western Medicine Therapy for chronic heart failure.
- Main Outcome
- NYHA Cardiac Function Classification and Left ventricular ejection fraction Measures of effect At least three months after the treatment.
- Outcome Measure
- Additional Outcome
- 6-minute walking distance and n-terminal pro-b-type natriuretic peptide Measures of effect At least three months after the treatment.
- Study Method
- Network meta-analysis, Systematic review
- Keyword
- Heart Failure; Humans; Medicine, East Asian Traditional; Network Meta-Analysis; Nonprescription Drugs
- Contact
- Yang Zhao [email protected]
- Organisational Affiliation
- Funding Source
- Self financing
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- Chinese-Simplified, English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2019-04-13
- Registration Date
- 2019-05-20
- Anticipated Start Date
- 2019-04-15
- Anticipated Completion Date
- 2019-06-30
- Title Cn
- 4种中成药治疗慢性心力衰竭的疗效与安全性：网状Meta分析
- Title En
- Efficacy and safety of 4 personal Chinese patent medicines in the treatment of chronic heart failure: a network meta-analysis
- Bilingual Status
- complete